Cibus (CBUS) Set to Announce Quarterly Earnings on Thursday

Cibus (NASDAQ:CBUS) is expected to announce its Q3 2026 results after the market closes on Thursday, November 12th. Analysts expect Cibus to announce earnings of ($0.2033) per share and revenue of $1.30 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 12, 2026 at 4:30 PM ET.

Cibus (NASDAQ:CBUS) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.10). The company had revenue of $0.99 million during the quarter, compared to the consensus estimate of $1.70 million. Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%. On average, analysts expect Cibus to post ($1.13) EPS for the current fiscal year and ($1.07) EPS for the next fiscal year.

Cibus Stock Up 8.8%

Shares of CBUS opened at $1.24 on Thursday. The firm’s 50 day simple moving average is $1.50 and its 200 day simple moving average is $1.84. Cibus has a 1-year low of $1.09 and a 1-year high of $4.19.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CBUS shares. Wall Street Zen cut shares of Cibus from a “hold” rating to a “sell” rating in a research note on Saturday, October 17th. Weiss Ratings restated a “sell (e+)” rating on shares of Cibus in a research report on Friday, September 25th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $9.00.

About Cibus

Cibus, Inc (NASDAQ: CBUS) is an agricultural biotechnology company focused on developing gene-edited crop traits. Its technology is designed to improve the performance, resilience and sustainability of important crops by making targeted changes to plant genetics without introducing foreign DNA.

The company’s proprietary Rapid Trait Development System (RTDS) supports the development of traits for crops including canola, rice, soybeans and wheat. Cibus has pursued applications such as herbicide tolerance, pod-shatter reduction and resistance to diseases and other environmental stresses, with the goal of helping growers improve yields, reduce crop losses and use agricultural inputs more efficiently.

Cibus serves the global agriculture industry through relationships with seed companies, growers and other participants in the crop-development and commercialization ecosystem.